Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MindMed

Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study

The psychedelics space was shaken up on the news that MindCure Health (OTC:MCURF) was shutting down operations. After a review process, the company’s board decided that MindCure’s business plan required more capital that it could gather under current market conditions, thus shutting down operations was considered the best move to preserve…

Novamind To Host MindMed Phase IIb Trial For LSD Based Drug For Anxiety Treatment

Novamind To Host MindMed Phase IIb Trial For LSD Based Drug For Anxiety Treatment

Novamind Inc. (OTCQB:NVMDF) (CSE:NM) (FSE:HN2) has been selected by Mind Medicine, Inc. (NASDAQ:MNMD) (NEO:MMED) to host a Phase IIb randomized clinical trial investigating lysergic acid diethylamide (LSD) for generalized anxiety disorder in adults.

LSD And Magic Mushroom's Active Compound Appear To Have The Same Effects, New Study Finds

LSD And Magic Mushroom's Active Compound Appear To Have The Same Effects, New Study Finds

A new peer-reviewed study compared the effects of LSD and psilocybin, two substances currently standing as top molecules behind the recent psychedelic medicine boom. While both compounds have a rich history of human use, not much research has been dedicated to contrasting the effects they produce in human psychology. The…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

MindMed Converts Shares To Have A Single Class

Psychedelics-focused biopharma company Mind Medicine Inc. (NASDAQ: MNMD), (NEO:MMED), (DE:MMQ) confirmed Wednesday that all the company’s issued and outstanding multiple voting shares will undergo a mandatory conversion into subordinate voting shares in accordance with the company&rsq

Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event

Media company Global Trac Solutions, Inc. (OTCP:PSYC) and authorities behind psychedelic news and information platform Psychedelic Spotlight, announced that Psychedelic Spotlight will host its first “CEO Roundtable” on Feb. 15.

Psyched: UK Streamlines MDMA Therapy, FDA OKs MindMed's First LSD Trial In 40 years, Atai Launches Subsidiary

The Week In Psychedelics

MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years

MindMed (NASDAQ: MNMD), a drug development company in the psychedelics space, announced on Tuesday that the FDA has allowed an investigational new drug application for a Phase 2b trial on a proprietary LSD analog.

inkl

Read news from The Economist, FT, and more,
with one subscription

MindMed Successfully Completes Phase 1 Trial Of 18-MC

MindMed Successfully Completes Phase 1 Trial Of 18-MC

This article was originally published on Microdose and appears here with permission.

MindMed Launches Study Using Monitoring System For Psychedelic Experiences

MindMed Launches Study Using Monitoring System For Psychedelic Experiences

Psychedelics biotech company MindMed (NASDAQ: MNMD) has enrolled the first subjects into its Session Monitoring System study. The company’s Session Monitoring System is a technology platform that can collect sensory data during a therapy session with a psychedelic drug.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Wikimedia Commons

Food and Drug Administration

Field Trip Health

Psychedelic Spotlight

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

102,350 stories

Washington State

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play